Evidence map›Paper›PMID 27257180›Full record

ArticleBlood2016

Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.

Janine Schmidt, Shunyou Gong, Teresa Marafioti, Barbara Mankel, Blanca Gonzalez-Farre, Olga Balagué, Ana Mozos, José Cabeçadas, Jon van der Walt, Daniela Hoehn and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 142 citations in OpenAlex.

  1. Blood · 2018
    Trial
  2. [Diagnostic challenges in pediatric lymphomas].Pathologie (Heidelberg, Germany) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pediatric lymphomas: overview and diagnostic challenges.Virchows Archiv : an international journal of pathology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. The pathobiology of follicular lymphoma.Journal of clinical and experimental hematopathology : JCEH · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Follicular lymphoma and marginal zone lymphoma: how many diseases?Virchows Archiv : an international journal of pathology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 6 countries.

Janine SchmidtInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Shunyou GongHematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
Teresa MarafiotiDepartment of Cellular Pathology, Barts and The London NHS Trust, London, United Kingdom;
Barbara MankelInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Blanca Gonzalez-FarreHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Olga BalaguéHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Ana MozosPathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
José CabeçadasPathology Department, Instituto Portugues de Oncología, Lisboa, Portugal;
Jon van der WaltDepartment of Histopathology, Guy's and St. Thomas Hospitals, London, United Kingdom;
Daniela HoehnDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY;
Andreas RosenwaldInstitute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany;
German OttDepartment of Clinical Pathology, Robert-Bosch-Hospital and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
Stefan DojcinovDepartment of Pathology, All Wales Lymphoma Panel, University Hospital of Wales, Cardiff, United Kingdom;
Caoimhe EganHematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
Ferran NadeuHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Joan Enric Ramis-ZaldívarHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Guillem ClotHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Carmen BárcenaHospital Universitario 12 de Octubre, Madrid, Spain;
Vanesa Pérez-AlonsoHospital Universitario 12 de Octubre, Madrid, Spain;
Volker EndrisInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; and.
Roland PenzelInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; and.
Carmen Lome-MaldonadoDepartment of Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Irina BonzheimInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Falko FendInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Elias CampoHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Elaine S JaffeHematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD;
Itziar SalaverriaHematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
Leticia Quintanilla-MartinezInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany;
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversity of Tübingen · DENational Cancer Institute · USHospital Universitario 12 De Octubre · ESUniversity Hospital Heidelberg · DEBarts Health NHS Trust · GBColumbia University Irving Medical Center · USDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEHospital de Sant Pau · ESInstituto Nacional de Cancerología · MXIPO Porto · PTSt Thomas' Hospital · GBUniversity Hospital of Wales · GBUniversity of Würzburg · DE

Funding

Lymphoma Disease Discovery and DefintionZIASC000550 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$16.9M
6 · The paper itself

Abstract

Pediatric-type follicular lymphoma (PTFL) is a variant of follicular lymphoma (FL) with distinctive clinicopathological features. Patients are predominantly young males presenting with localized lymphadenopathy; the tumor shows high-grade cytology and lacks both BCL2 expression and t(14;18) translocation. The genetic alterations involved in the pathogenesis of PTFL are unknown. Therefore, 42 PTFL (40 males and 2 females; mean age, 16 years; range, 5-31) were genetically characterized. For comparison, 11 cases of conventional t(14:18)(-) FL in adults were investigated. Morphologically, PTFL cases had follicular growth pattern without diffuse areas and characteristic immunophenotype. All cases showed monoclonal immunoglobulin (IG) rearrangement. PTFL displays low genomic complexity when compared with t(14;18)(-) FL (mean, 0.77 vs 9 copy number alterations per case; P <001). Both groups presented 1p36 alterations including TNFRSF14, but copy-number neutral loss of heterozygosity (CNN-LOH) of this locus was more frequently observed in PTFL (40% vs 9%; P =075). TNFRSF14 was the most frequently affected gene in PTFL (21 mutations and 2 deletions), identified in 54% of cases, followed by KMT2D mutations in 16%. Other histone-modifying genes were rarely affected. In contrast, t(14;18)(-) FL displayed a mutational profile similar to t(14;18)(+) FL. In 8 PTFL cases (19%), no genetic alterations were identified beyond IG monoclonal rearrangement. The genetic landscape of PTFL suggests that TNFRSF14 mutations accompanied by CNN-LOH of the 1p36 locus in over 70% of mutated cases, as additional selection mechanism, might play a key role in the pathogenesis of this disease. The genetic profiles of PTFL and t(14;18)(-) FL in adults indicate that these are two different disorders.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAdolescentAdultChildChild, PreschoolChromosomes, Human, Pair 14Chromosomes, Human, Pair 18Clone CellsCytogenetic AnalysisDNA Copy Number VariationsDNA Mutational AnalysisExonsFemaleHumansIn Situ Hybridization, FluorescenceReceptors, Tumor Necrosis Factor, Member 14TNFRSF14 protein, human

Identifiers

PMID27257180
PMCPMC5000845
OpenAlexW2418011425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.